Search

everythinglearnresearchcommunity

for

Search:↓

Oxytocin receptors are found in skin cells near touch and pain neurons.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Stress may trigger hair loss by affecting immune protection in hair follicles.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

HIV can cause unusual and severe skin problems that are hard to treat.

PCOS is linked to low-grade chronic inflammation.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Histone modification is key in treating chronic inflammatory skin diseases.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.